Previous reports have shown that RUNX3 expression was reduced in numerous types of human cancers, such as breast cancer, colorectal cancer, renal cell carcinoma, melanoma [8], [11], [13], [18]. Here, RUNX3 is linked to hereditary clear cell renal cell carcinoma.